NeoGenomics Inc. (NEO)

20.25
0.18 0.88
NASDAQ : Health Services
Prev Close 20.43
Open 20.27
Day Low/High 19.95 / 20.38
52 Wk Low/High 11.05 / 26.89
Volume 592.07K
Avg Volume 843.00K
Exchange NASDAQ
Shares Outstanding 103.86M
Market Cap 2.12B
EPS 0.10
P/E Ratio 681.00
Div & Yield N.A. (N.A)
NeoGenomics Has Attractive Charts and Should Continue Its Uptrend

NeoGenomics Has Attractive Charts and Should Continue Its Uptrend

Let's see what the charts suggest.

When Bad News Is Good News: Cramer's 'Mad Money' Recap (Friday 9/6/19)

When Bad News Is Good News: Cramer's 'Mad Money' Recap (Friday 9/6/19)

Disappointing payroll data report gives the Fed room to cut interest rates, says Jim Cramer. He's got your game plan for next week.

Yeti Holdings, Neogenomics, Nutanix: 'Mad Money' Lightning Round

Yeti Holdings, Neogenomics, Nutanix: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti Holdings, Neogenomics, Nutanix, Cadence Systems and more.

NeoGenomics Reaches Analyst Target Price

NeoGenomics Reaches Analyst Target Price

In recent trading, shares of NeoGenomics Inc have crossed above the average analyst 12-month target price of $23.67, changing hands for $24.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.

Home Depot, Neogenomics, Ball Corp.: 'Mad Money' Lightning Round

Home Depot, Neogenomics, Ball Corp.: 'Mad Money' Lightning Round

Jim Cramer is taking a closer look at Home Depot, Neogenomics, Ball Corp., Mercer International, Lumentum Holdings, Synopsys, Olin, and CommScope.

NeoGenomics Reaches Analyst Target Price

NeoGenomics Reaches Analyst Target Price

In recent trading, shares of NeoGenomics Inc have crossed above the average analyst 12-month target price of $20.43, changing hands for $20.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luxfer Holdings And Neo Performance Materials Mutually Agree To Terminate Acquisition Agreement

Luxfer Holdings And Neo Performance Materials Mutually Agree To Terminate Acquisition Agreement

Luxfer Holdings PLC (NYSE: LXFR) ("Luxfer") and Neo Performance Materials Inc. (TSX: NEO) ("Neo Performance Materials" or "Neo") today announced that the companies have mutually agreed to terminate the previously announced transaction (the "Neo...

NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip

NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip

Let's check out the charts and indicators for a strategy that looks to balance risk and reward.

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

Jim Cramer takes a closer look at today's pin action, and talks about why the weakness didn't spread.

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

Jim Cramer weighs in on CVS Health, Neogenomics, Vicor, WD-40, T. Rowe Price, Clorox and more.

First Week Of NEO August 16th Options Trading

First Week Of NEO August 16th Options Trading

Investors in NeoGenomics Inc saw new options begin trading this week, for the August 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 225 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Luxfer Holdings To Acquire Neo Performance Materials

Luxfer Holdings To Acquire Neo Performance Materials

Luxfer Holdings PLC (NYSE: LXFR) ("Luxfer") and Neo Performance Materials Inc. (TSX: NEO) ("Neo Performance Materials" or "Neo") today announced the signing of a definitive agreement under which Luxfer would acquire Neo Performance Materials for US$612...

Interesting NEO Put And Call Options For May 2019

Interesting NEO Put And Call Options For May 2019

Investors in NeoGenomics Inc saw new options become available this week, for the May 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 227 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

NEO Crosses Above Average Analyst Target

NEO Crosses Above Average Analyst Target

In recent trading, shares of NeoGenomics Inc have crossed above the average analyst 12-month target price of $14.67, changing hands for $14.93/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

NEO Crosses Above Average Analyst Target

In recent trading, shares of NeoGenomics Inc have crossed above the average analyst 12-month target price of $10.80, changing hands for $10.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week of August 17th Options Trading For NeoGenomics (NEO)

First Week of August 17th Options Trading For NeoGenomics (NEO)

Investors in NeoGenomics Inc saw new options begin trading this week, for the August 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 210 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

NeoGenomics is Now Oversold (NEO)

NeoGenomics is Now Oversold (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For NeoGenomics (NEO)

Oversold Conditions For NeoGenomics (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NEO Crosses Above Average Analyst Target

NEO Crosses Above Average Analyst Target

In recent trading, shares of NeoGenomics Inc have crossed above the average analyst 12-month target price of $10.89, changing hands for $11.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

NeoGenomics Becomes Oversold (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NeoGenomics And Definiens Enter Into Agreement To Develop Novel Assays For Clinical Trials & Clinical Testing

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today...

Short Interest In NeoGenomics Declines 33%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 2,130,398 share decrease in total short interest for NeoGenomics Inc , to 4,342,908, a decrease of 32.91% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

NeoGenomics is Now Oversold (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

Short Interest In NeoGenomics Increases 60%

Short Interest In NeoGenomics Increases 60%

The most recent short interest data has been released for the 09/15/2016 settlement date, which shows a 2,156,736 share increase in total short interest for NeoGenomics Inc , to 5,757,216, an increase of 59.90% since 08/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

NeoGenomics Enters Oversold Territory (NEO)

NeoGenomics Enters Oversold Territory (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NEO: Insiders vs. Shorts

NEO: Insiders vs. Shorts

The most recent short interest data was recently released for the 06/30/2016 settlement date, and NeoGenomics Inc is one of the most shorted stocks of the Russell 3000, based on 5.81 "days to cover" versus the median component at 4.51. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Everybody's Doing It: 5 Stocks Under $10 That I Like

Everybody's Doing It: 5 Stocks Under $10 That I Like

These have positive momentum and good growth.